USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER

USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER

Show other versions (1)

The majority of clinical trials included a thoroughly selected population of patients predominantly with clear-cell renal cell carcinoma (RCC), without brain metastases and with a good somatic status. Due to the fact that in routine practice, the patient population is more heterogeneous (patients wi...

Full description

Bibliographic Details
Main Authors: B. Ya. Alekseev, A. S. Kalpinskiy
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkourologiâ
Subjects:
metastatic renal cell carcinoma
targeted therapy
tyrosine kinase inhibitors
Online Access:http://oncourology.abvpress.ru/index.php/oncur/article/view/46

Internet

http://oncourology.abvpress.ru/index.php/oncur/article/view/46

Similar Items